Abstract:Compared to the conventional anti-cancer drugs, the nano-drug delivery systems (NDDS) shows a comparatively ideal therapeutic efficacy ascribing their high tumor-target capacity and efficient drug release ability. In this study, a novel macromolecular prodrug conjugate was designed and developed that is passively triggered by the acidic environment of the tumor cells and can release doxorubicin (Dox). The susceptibility of the system to the acidic environment is due to the acid volatile Schiff base covalent bond between grafted carboxymethyl chitosan (CMCs) and Dox. The chemical structure of the finalized system was characterized by 1H-NMR spectroscopy. Because of the hydrophobicity of the Dox and the hydrophilicity of the CMCs, the amphipathic polymeric drug conjugates can self-assemble into the nanoparticles in aqueous solution. The morphology and size of the nanoparticles were observed with TEM (transmission electron microscopy) and DLS (dynamic light scattering). The in vitro drug release studies demonstrated that the drug release rate of the prodrug were visibly higher in acidic conditions (pH 5.0) compared to higher pHs like 6.5 and 7.4. DLS results showed that the mean size of the prodrug nanoparticles increased as the pH of the solution decreased from 7.4 to 6.5 and 5.0. Furthermore, the cell counting kit-8 (CCK-8) assays showed that the polymeric drug nanoparticles had a cytotoxic effect on SKOV3 ovarian cancer cells while the segments of the DDS revealed comparatively lower cytotoxic effect. Moreover, confocal laser scanning microscopy (CLSM) showed that the prodrug could efficiently deliver and release Dox in the nuclei of the cancer cells while this was not observed for the Dox pure drug. These results proved that the carboxymethyl chitosan-CBA-Doxorubicin NPs have superior stabilities, low toxicities, proper sizes, and enhanced curable efficiency for in vitro controlled release. Thus, this pH-sensitive prodrug could be a potential treatment for cancer therapy in the near future.

Unveiling the molecular mechanism of pH-dependent interactions of human serum albumin with chemotherapeutic agent doxorubicin: A combined spectroscopic and constant-pH molecular dynamics study

Acid-responsive intracellular doxorubicin release from click chemistry functionalized mesoporous silica nanoparticles

Human Serum Albumin-Based Doxorubicin Prodrug Nanoparticles with Tumor Ph-Responsive Aggregation-Enhanced Retention and Reduced Cardiotoxicity.

Enzyme/pH-sensitive Polyhpma-Dox Conjugate As a Biocompatible and Efficient Anticancer Agent

Structure-Activity Relationship of Ph-Sensitive Doxorubicin-Fatty Acid Prodrug Albumin Nanoparticles

Dual Actions of Albumin Packaging and Tumor Targeting Enhance the Antitumor Efficacy and Reduce the Cardiotoxicity of Doxorubicin in Vivo

Hollow Mesoporous Silica@Metal-Organic Framework and Its Applications for pH-Responsive Doxorubicin Drug Delivery.

Synthesis of the pH-sensitive nanoparticles based on the acylhydrazone bonds conjugated doxorubicin and studies on their in vivo anti-tumor effects

Determination of the optimal pH for doxorubicin encapsulation in polymeric micelles

The interaction of bovine serum albumin with doxorubicin-loaded superparamagnetic iron oxide nanoparticles: spectroscope and molecular modelling identification.

The effect of simultaneous binding of doxorubicin and cyclophosphamide on the human serum albumin structure

Probing the Anticancer-Drug-binding-induced Microenvironment Alterations in Subdomain IIA of Human Serum Albumin.

Spectroscopic Investigation on the Binding of Antineoplastic Drug Oxaliplatin to Human Serum Albumin and Molecular Modeling

Balancing Efficacy and Safety of Doxorubicin-Loaded Albumin Nanoparticles Utilizing Ph-Sensitive Doxorubicin-Fatty Acid Prodrugs

Structural Distortion of β-Cyclodextrin Plays a Key Role in the pH-dependent Host-Guest Chemistry with Doxorubicin, Evident by the Electrochemical and Molecular Dynamics Approach

The design and synthesis of dextran-doxorubicin prodrug-based pH-sensitive drug delivery system for improving chemotherapy efficacy

Synthesis and in Vitro Characterization of Carboxymethyl Chitosan-CBA-Doxorubicin Conjugate Nanoparticles As Ph-Sensitive Drug Delivery Systems

Coordination Bonding-Based Mesoporous Silica for Ph-Responsive Anticancer Drug Doxorubicin Delivery

Molecular Dynamics Study on the Encapsulation and Release of Anti-cancer Drug Doxorubicin by Chitosan.

Specific interaction of 4'-O-(a-l-Cladinosyl) daunorubicin with human serum albumin: The binding site II on HSA molecular using spectroscopy and modeling.

A Ph-Sensitive Doxorubicin Prodrug Based on Folate-Conjugated BSA for Tumor-Targeted Drug Delivery